In the December 27 e-Alert, we wrote to you about a new way to assess your risk of heart disease. It’s the ratio between apolipoprotein B (apo B) and apolipoprotein A-1 (apo A-1), and studies have shown it can be even more meaningful than the HDL/LDL ratio. In fact, in the study I wrote about last month, men with the highest levels of apo B and the lowest levels of apo A-1 were nearly FOUR TIMES as likely to have a fatal heart attack than those with opposite values. (You can view this e-Alert on our website, www.hsibaltimore.com, on the “Current e-Alerts” page.)

Read More


• A Potent and Safe Thrombolytic: By Martin Milner, N.D.

Clotting is a key, often overlooked factor in chronic illness, and with
nattokinase, we know how to reverse it. This is where the real treasure of
this enzyme lies. Disorders such as heart disease, hypertension, fibromyalgia,
chronic infection, inflammatory bowel disease, deep vein thrombosis, may
respond to nattokinase.
Turn to page 2 for more on A Potent and Safe Thrombolytic
By dissolving branched fibrin–which coagulates prior to full clot formation–
nattokinase proves uniquely helpful in many disorders.
Turn to page 2 for more on Doctors Apply Nattokinase in Many Conditions
Nattokinase: Clinical Updates from
Doctors Support its Safety and Efficacy
• Doctors Apply Nattokinase in Many Conditions
• Four Top Doctors Weigh In
Hear how Jonathan Wright, M.D., David Brownstein, N.D., Christopher
Deatherage, N.D., and Stephen Hines, N.D. use this powerful,
fibrinolytic enzyme.

Read More